Tru Niagen Stick Packs 300 mg by Tru Niagen

If you’ve been searching for “nicotinamide riboside benefits,” this fits healthy adults who want a measurable NAD+ boost for energy metabolism as they hit their 30s and beyond. It’s useful if long work hours, shift schedules, hard training, or frequent travel leave you feeling drained despite normal Thyroid-Stimulating Hormone and complete blood count. It also suits people who can’t tolerate niacin (the flushing B3), and those focused on healthy aging markers over years, not days.

Nicotinamide riboside is a form of vitamin B3 your cells convert efficiently into NAD+ (the coenzyme that lets mitochondria turn food into ATP energy). Higher NAD+ also activates sirtuins (enzymes that help with DNA maintenance and metabolic balance) and fuels PARPs (DNA repair enzymes). Unlike niacin (nicotinic acid), it raises NAD+ without skin flushing. Human trials show blood NAD+ rises within 1 to 2 weeks at doses in this range.

Mix one Tru Niagen stick pack in about 16 ounces of water daily, morning or early afternoon, with or without food. Most people stay at 300 mg; some clinicians trial 300–600 mg for a few weeks, then return to the lower dose for maintenance. If late dosing affects sleep, move it earlier. If you use strong coffee or pre-workouts, separate by an hour to judge each effect cleanly.

Active cancer is a reason to pause nicotinamide riboside and discuss with your oncologist, since rapidly dividing cells also use NAD+. Pregnancy and breastfeeding lack safety data, so avoid. High doses can increase methylation demand, which can nudge homocysteine (an amino acid tied to vascular risk) upward; if yours runs high, ensure adequate folate, vitamin B12, and consider trimethylglycine, then recheck Homocysteine after 4 to 8 weeks.

Most people see NAD+ rise quickly; subjective energy changes are more variable and usually show up within 2 to 4 weeks if you’re a responder. Effects on day-to-day stamina are modest compared with sleep, training, and nutrition basics. If you’re choosing between NR and NMN, NR has FDA-notified GRAS status and broad human data; NMN’s regulatory status has been in flux in the U.S.